uniQure N.V. Uncategorized Contracts & Agreements
10 Contracts & Agreements
- Letter Agreement dated October 5, 2023, by and between Richard Porter and Corlieve Therapeutics AG (Filed With SEC on February 28, 2024)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2024)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2023)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 25, 2022)
- t Equity Side Letter, effective May 17, 2021, by and between uniQure N.V. and Pierre Caloz (Filed With SEC on July 26, 2021)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 1, 2021)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2020)
- 113 Hartwell Avenue Lexington, Massachusetts (the Building) FIRST AMENDMENT As of November 9, 2018 (Execution Date) (Filed With SEC on November 15, 2018)
- uniQure biopharma B.V. Paasheuvelweg 25a 1105BP Amsterdam The Netherlands (Filed With SEC on August 8, 2017)
- (signature Lessee) (Filed With SEC on March 15, 2017)
